Get started
Author

Jin Shu

Observed names: Shu Chang Jin, Shu Jin
Observed institutions: Chongqing University, Shanghai Jiao Tong University, Renmin Hospital of Wuhan University, Principia Biopharma (United States), Chongqing Cancer Hospital, Shanghai Institute of Immunology
ORCID: 0000-0002-0622-3219
Observed ORCID: 0000-0002-0622-3219
OpenAlex ID: A5064779408
Prolonged and tunable residence time using reversible covalent kinase inhibitors
2015 · J Michael Bradshaw, Jesse M McFarland, et al. · Nature Chemical Biology · 439
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease
2021 · Claire L Langrish, J Michael Bradshaw, et al. · The Journal of Immunology · 140
PDF
Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors
2017 · Ken A. Brameld, Timothy D. Owens, et al. · Journal of Medicinal Chemistry · 104
Discovery of Reversible Covalent Bruton’s Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
2022 · Timothy D. Owens, Ken A. Brameld, et al. · Journal of Medicinal Chemistry · 101
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)
2021 · Timothy D. Owens, Patrick F. Smith, et al. · Clinical and Translational Science · 54
PDF
A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma
2022 · Lingfang Xia, Qi Zhou, et al. · Nature Communications · 34
PDF
Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
2023 · Sibel Ucpinar, Patrick F. Smith, et al. · Clinical and Translational Science · 21
PDF
Preclinical Mechanisms of Topical PRN473, a Bruton Tyrosine Kinase Inhibitor, in Immune-Mediated Skin Disease Models
2021 · Yan Xing, Katherine A Chu, et al. · ImmunoHorizons · 21
Humoral immune responses against tumor‐associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity
2008 · Shu Jin, Ying Wang, et al. · Cancer Science · 19
PDF
Licochalcone A inhibits IgE-mediated allergic reaction through PLC/ERK/STAT3 pathway
2022 · Jin Shu, Xu Cui, et al. · International Journal of Immunopathology and Pharmacology · 17
Hyperuricemia is associated with metabolic syndrome: A cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES)
2023 · Jin Shu, Rushun Zhao, et al. · Preventive Medicine Reports · 15
All-trans-retinoic Acid Promotes Iodine Uptake Via Up-regulating the Sodium Iodide Symporter in Medullary Thyroid Cancer Stem Cells
2014 · Min Tang, Yan-Li Hou, et al. · Asian Pacific Journal of Cancer Prevention · 13
PDF
A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects
2022 · Sibel Ucpinar, Borje Darpo, et al. · Clinical and Translational Science · 8
[Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].
2005 · Shu Jin, Ying Wang, et al. · PubMed · 4
Gadopentetate meglumine activates mast cells to cause IgE-independent allergic reactions both in vitro and in vivo
2022 · Xin Liu, Yufei Zhang, et al. · International Immunopharmacology · 3
Study of Migration of Different Petroleum Hydrocarbon Contaminated Components in Soil
2011 · Xiao Nan Sun, An Ping Liu, et al. · Advanced materials research · 3
[Analysis of the hearing of patients with obstructive sleep apnea-hypopnea syndrome].
2006 · Yongmao Cao, Zhihong Luo, et al. · PubMed · 3
Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101): An open-label, phase II clinical trial.
2021 · Haixia Wang, Jin Shu, et al. · Journal of Clinical Oncology · 1
Research on the Migration of Petroleum Hydrocarbon Contamination in the Soil in Different Leaching Amount
2011 · Xiao Nan Sun, An Ping Liu, et al. · Advanced materials research · 1
Abstract 2091: PRN1371, an irreversible, covalent inhibitor of FGFR1-4 exhibits sustained pathway inhibition in cancer cell lines
2017 · Eleni Venetsanakos, Yan Xing, et al. · Cancer Research
Abstract 1249: PRN1371, an irreversible, covalent inhibitor of FGFR1, 2, 3 and 4 is highly efficacious in preclinical tumor models
2016 · Eleni Venetsanakos, Michael Bradshaw, et al. · Cancer Research
Correlations between serum levels of 25-(OH) D3 and changes in Th1/Th2 cell balance in infants with recurrent wheezing
2015 · XU Yan-na, Gu Jianhua, et al. · Zhonghua shiyong erke linchuang zazhi
Gamma interferon release test for early diagnosis of tuberculosis
2014 · Jin Shu · Journal of clinical and experimental medicine
Efficacy of TCM retention enema on prevention in cervical cancer patients radiation proctitis
2012 · Jin Shu
Quantitative Evaluation of a Typical Petroleum Hydrocarbon Contaminated Site
2011 · An Ping Liu, Xiao Nan Sun, et al. · Advanced materials research
Works count: 30
Citation count: 1,001
H-index: 12
I10-index: 12
Year
Topic
Type